US FDA to establish medical policy council within drug centre
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration plans to establish a new council within its Center for Drug Evaluation and Research aimed at providing a senior level forum for deliberations about medical policy issues, CDER director Janet Woodcock revealed in an internal memo to her staff1.